.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a growing global epidemic. Experts now categorize MASLD as a hepatic manifestation of systemic metabolic disorders. This condition involves insulin resistance, obesity, and chronic inflammation. Understanding the epigenetic mechanisms in MASLD is essential for identifying patients at high risk of progression. These mechanisms allow environmental factors to influence gene activity without changing the primary DNA sequence.
Recent research highlights several key drivers of liver dysfunction. DNA methylation stands out as a primary regulatory process. It involves the addition of methyl groups to CpG sites, which often silences protective genes. Histone modifications also play a significant role by altering chromatin accessibility. Consequently, these changes can trigger lipid accumulation and promote fibrogenesis in the liver. Furthermore, non-coding RNAs regulate post-transcriptional gene expression. In addition, N6-methyladenosine (m6A) modifications influence the stability of hepatic RNA transcripts. Each of these components contributes to the transition from simple steatosis to severe steatohepatitis.
MASLD correlates strongly with an increased risk of cardiovascular disease. This risk persists regardless of traditional factors like diabetes or hypertension. Interestingly, many epigenetic changes remain reversible through lifestyle or pharmacological interventions. This characteristic makes them ideal targets for developing new therapeutic strategies. Moreover, clinicians can use these markers for better risk stratification. By monitoring specific biomarkers, physicians may soon offer personalized treatment plans for fibrosis. Therefore, staying informed about these biological advances is vital for modern hepatology practice.
The main drivers include DNA methylation, histone modifications, and non-coding RNA regulation. These processes allow environmental factors to alter gene expression without changing the DNA sequence.
MASLD increases the risk of cardiovascular disease independently of traditional risk factors like obesity or hypertension. It is often viewed as the hepatic manifestation of a systemic metabolic syndrome.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Zhelezniakova N et al. The Influence of Epigenetic Mechanisms on the Development of Metabolic Dysfunction Associated Steatotic Liver Disease: A Review. J Gastrointestin Liver Dis. 2026 Mar 27. doi: 10.15403/jgld-6581. PMID: 41894713.
Zheng Q et al. Epigenetic and epitranscriptomic regulations of metabolic dysfunction-associated steatotic liver disease. Metabolism and Target Organ Damage. 2024;4:43. doi:10.20517/mtod.2024.75.
Li X et al. Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatment. PMC. 2025 Mar 17.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Explore the role of epigenetic mechanisms in MASLD, focusing on DNA methylation and histone modifications as drivers of disease progression and therapy....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
